RAF signaling in neuroendocrine neoplasms: from bench to bedside.


Neuroendocrine neoplasms are a low-incidence and heterogeneous group of malignancies. In the advanced stage, several therapeutic options can be discussed, including molecular-targeted agents, but biological predicting factors are lacking. A number of molecular targets have been studied over the last decade leading to several phase II studies; however, very… (More)
DOI: 10.1016/j.ctrv.2014.06.009


  • Presentations referencing similar topics